A5060707121- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Cardiac, Anesthesia and Surgical Outcomes
- Aortic Disease and Treatment Approaches
- Congenital Heart Disease Studies
- Coronary Artery Anomalies
- Venous Thromboembolism Diagnosis and Management
- Pericarditis and Cardiac Tamponade
- Lung Cancer Treatments and Mutations
- Vascular anomalies and interventions
- Aortic aneurysm repair treatments
- Coronary Interventions and Diagnostics
- Cardiovascular Health and Disease Prevention
- Cardiac tumors and thrombi
- Tumors and Oncological Cases
- Oropharyngeal Anatomy and Pathologies
- Respiratory Support and Mechanisms
- Cerebrovascular and Carotid Artery Diseases
- Cardiovascular Health and Risk Factors
- Cardiac Health and Mental Health
University of Illinois Chicago
2020-2024
Cardiovascular Institute of the South
2023-2024
Northwestern University
2023-2024
Northwestern Memorial Hospital
2024
Indo-American Center
2021
Mayo Clinic
2018-2020
Mayo Clinic in Arizona
2018-2019
University of Minnesota Rochester
2018
Creighton University
2015
Aortic stenosis (AS) is a common form of valvular heart disease, present in over 12% the population age 75 years and above. Transthoracic echocardiography (TTE) first line imaging adjudication AS severity but time-consuming requires expert sonographic interpretation capabilities to yield accurate results. Artificial intelligence (AI) technology has emerged as useful tool address these limitations not yet been applied fully hands-off manner evaluate AS. Here, we correlate artificial neural...
Abstract Aims Differentiating cardiac amyloidosis (CA) subtypes is important considering the significantly different therapies for transthyretin (ATTR)-CA and light chain (AL)-CA. Therefore, an echocardiographic method to distinguish ATTR-CA from AL-CA would provide significant value. We assessed a novel pixel intensity quantify myocardial calcification differentiate phenocopies of CA AL-CA, specifically. Methods results 167 patients with (n = 53), 32), hypertrophic cardiomyopathy 37),...
The patient’s many problems include ventricular tachycardia, requiring an implanted cardioverter-defi brillator and amiodarone.
e17590 Background: Race and insurance status are socio-demographic characteristics that influence extensive stage (Stage IV) lung cancer incidence (Halpern MT, et al. (2008) Association of ethnicity with at diagnosis for 12 sites: a retrospective analysis. Lancet Oncol 9:222-232.). This is the largest study looking small cell (SCLC) to determine epidemiological patient features associated disease. Methods: A population-based using National Cancer Database (2000-2012), which contains 70% all...
6558 Background: Demographic characteristics, especially race and insurance status, affect the incidence of lung cancer diagnosed at Stage IV1. This is largest epidemiological study to determine patient features associated with development IV NSCLC. Methods: A population-based using National Cancer Database (2000-2012), which contains 70% all diagnoses in U.S. from 1658 ACS Accredited-Hospitals. groups NSCLC presenting were compared entire cohort patients Chi square test. Results: Of...